Question 1

How many institutions own LIPO stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own LIPO shares is 1, representing 1.3% of the company's common stock.

Question 2

Who are the major shareholders selling Lipella Pharmaceuticals Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in LIPO by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the LIPO shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned LIPO shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying LIPO stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in LIPO by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of LIPO to its portfolio, raising its holding to - shares of worth -. N/A also increased its LIPO shares holding by N/A which brought its holding to - shares worth -.

Question 4

LIPO's major insiders: who are they?

Accepted Answer

The insider with the most stakes in LIPO is N/A , N/A at the company. Additionally, LIPO stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell LIPO stock?

Accepted Answer

Company executives, directors, and other insiders own 6.31% percent of Lipella Pharmaceuticals Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which LIPO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased LIPO stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Lipella Pharmaceuticals Inc. insiders have bought stock, totalling 0 shares

Question 7

How much of LIPO does insiders own?

Accepted Answer

Around 0 Lipella Pharmaceuticals Inc. shares are held by insiders, which represents about 6.31% of LIPO stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

LIPO N/A, N/A holds the largest portfolio of the company's shares. LIPO shares owned by N/A total nearly -.

Question 9

Which institution holds the most shares in LIPO?

Accepted Answer

N/A is the largest institutional owner in LIPO which holds - shares worth - or N/A of the total LIPO shares outstanding followed by N/A with ownership of - shares representing N/A of the LIPO ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Lipella Pharmaceuticals Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the LIPO is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on LIPO's shares?

Accepted Answer

Number of LIPO shares short is 100.09K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding LIPO shares are there?

Accepted Answer

As of today, 4.47M shares of LIPO are outstanding.

Question 13

Is there many float in LIPO stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, LIPO has 4.33M shares in float.

Question 14

LIPO short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for LIPO is 3.32.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
May 14, 2024	KAUFMAN JONATHAN H	PURCHASE	0.76	10K	7.59K	898.85K
Mar 19, 2024	KAUFMAN JONATHAN H	PURCHASE	0.87	25K	21.8K	888.85K
Mar 18, 2024	KAUFMAN JONATHAN H	PURCHASE	0.79	30K	23.65K	863.85K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
May 14, 2024	KAUFMAN JONATHAN H	PURCHASE	0.76	10K	7.59K	898.85K
Mar 19, 2024	KAUFMAN JONATHAN H	PURCHASE	0.87	25K	21.8K	888.85K
Mar 18, 2024	KAUFMAN JONATHAN H	PURCHASE	0.79	30K	23.65K	863.85K

LIPO Stock Ownership Breakdown

Lipella Pharmaceuticals

Stock Outstanding Shares

Market Insider

Institutional Ownership

Buying/Selling by Insiders

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Buying/Selling by Insiders

Frequently Asked Questions